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ADIPOR1 is essential for vision and
its RPE expression is lost in the
Mfrprd6 mouse
Valentin M. Sluch 1, Angela Banks1, Hui Li1, Maura A. Crowley1, Vanessa Davis2,
Chuanxi Xiang1, Junzheng Yang1, John T. Demirs1, Joanna Vrouvlianis1, Barrett Leehy1,
Shawn Hanks1, Alexandra M. Hyman 1, Jorge Aranda1, Bo Chang3, Chad E. Bigelow1 &
Dennis S. Rice1
The knockout (KO) of the adiponectin receptor 1 (AdipoR1) gene causes retinal degeneration. Here
we report that ADIPOR1 protein is primarily found in the eye and brain with little expression in other
tissues. Further analysis of AdipoR1 KO mice revealed that these animals exhibit early visual system
abnormalities and are depleted of RHODOPSIN prior to pronounced photoreceptor death. A KO of
AdipoR1 post-development either in photoreceptors or the retinal pigment epithelium (RPE) resulted
in decreased expression of retinal proteins, establishing a role for ADIPOR1 in supporting vision in
adulthood. Subsequent analysis of the Mfrprd6 mouse retina demonstrated that these mice are lacking
ADIPOR1 in their RPE layer alone, suggesting that loss of ADIPOR1 drives retinal degeneration in this
model. Moreover, we found elevated levels of IRBP in both the AdipoR1 KO and the Mfrprd6 models.
The spatial distribution of IRBP was also abnormal. This dysregulation of IRBP hypothesizes a role for
ADIPOR1 in retinoid metabolism.
The adiponectin receptor 1 (ADIPOR1) gene encodes a seven transmembrane protein named for its purported
cognate ligand adiponectin, a secreted hormone that is inversely correlated with development of obesity, insulin
resistance, and type 2 diabetes1,2. It has been reported that adiponectin acts through binding to its receptors,
adiponectin receptors 1 and 2 (ADIPOR1 and ADIPOR2), respectively1,2, and this relationship has been further
propagated by studies that have shown that ablation of AdipoR1/AdipoR2 in mice led to the induction of insulin
resistance and glucose intolerance3. However, a contemporaneous study reported that AdipoR1 knockout (KO)
mice did not develop insulin resistance while AdipoR2 KO mice were actually protected from developing this
pathology when fed a high-fat diet4. In addition to this discrepancy, it has recently been shown that the AdipoR1
KO developed retinal degeneration while the KO of adiponectin did not5, suggesting that ADIPOR1 can definitively act independently of adiponectin. This function of ADIPOR1 in the eye rather than in glucose metabolism
is further underscored by the novel discovery of two different ADIPOR1 mutations that cause retinitis pigmentosa
in humans6,7 while mutations causing insulin resistance have thus far not been identified8.
In the previous study of AdipoR1 KO-induced retinal degeneration it was shown that the KO mice had developed a flecked retina, an accumulation of subretinal macrophages/microglia, highly diminished electroretinograms (ERGs) prior to significant photoreceptor loss, and a severe preferential deficiency of docosahexaenoic acid
(DHA) in the eye5. In an effort to better understand this biology, we have identified a specific anti-ADIPOR1 antibody capable of discriminating between wildtype (WT) and KO cells and tissues. We profiled ADIPOR1 protein
distribution across mouse tissues and found that unlike its near-ubiquitous mRNA levels1 this protein is enriched
specifically in the eye and the brain with little relative expression in the other tissues, such as liver and skeletal
muscle. Furthermore, in the retina we observed ADIPOR1 expression in photoreceptors and the retinal pigment
epithelium (RPE). We then went on to demonstrate a role for ADIPOR1 post-development by knocking it out
from adult floxed animals using either RPE or photoreceptor-specific Cre expression which resulted in decreased
expression of multiple retinal markers, establishing an important role for this protein in both of these cell types.
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Additionally, we characterized protein levels in AdipoR1 KO mouse retinas to show that these mice are
depleted of RHODOPSIN and other visual system proteins by three weeks of age, presenting an alternative
hypothesis for the observed low DHA levels. We also profiled the membrane frizzled related protein mutant
mouse9 (a de facto KO model known as Mfrprd6) that exhibits a retinal phenotype very similar to the AdipoR1 KO
mice. Remarkably, absence of MFRP caused a loss of ADIPOR1 specifically in the RPE layer, while expression of
ADIPOR1 persisted in the photoreceptors. Lastly, we profiled gene expression between AdipoR1 WT, heterozygous (HET), and KO animals and found that the interphotoreceptor retinoid-binding protein (IRBP, aka RBP3)
was strongly upregulated in KO eyes prior to retinal degeneration, suggesting retinoid metabolism dysfunction.
Subsequent analysis of Mfrprd6 mouse eyes also identified an IRBP increase in these mice prior to retinal degeneration akin to the AdipoR1 KO mice.

Results

Antibody screen identifies a specific anti-ADIPOR1 antibody that highlights restricted protein
expression among different tissues. In order to gain further insights into ADIPOR1 biology, we first

wanted to identify an antibody to study ADIPOR1 protein levels as well as cell and tissue distribution. While
a number of publications on ADIPOR1 have relied on transcript levels to profile its expression1,5,10, perhaps
in part due to lacking a trustworthy antibody reagent, this dependency on transcript levels may be misleading
since mRNA levels do not always correlate well with protein11,12, especially across different tissues13. Therefore,
we screened a number of commercially available antibodies for their ability to detect ADIPOR1. We utilized
HEK293T cells as a model to profile the antibodies as these cells are easy to transfect and have been reported
to express endogenous ADIPOR1 protein14. First, we tested whether we could detect exogenous Flag-tagged
ADIPOR1 from a plasmid transfection. During sample optimization for western blot analysis, we noted that
this overexpressed ADIPOR1 exhibited temperature sensitivity as heating the protein samples to a temperature
of 60 °C or greater led to a loss of detectable anti-Flag signal (Supplementary Fig. 1). Therefore, we chose to only
heat protein samples to a temperature of 37 °C for subsequent SDS-PAGE analysis. To generate a negative control
of antibody specificity for our study, we utilized CRISPR-Cas9 to knock out ADIPOR1 from HEK293T cells and
confirmed two independent clones to be ADIPOR1 KOs by DNA sequencing. Then we tested fifteen anti-ADIPOR1 antibodies on ADIPOR1-plasmid transfected, WT, CRISPR control (treated with non-genome targeting
gRNAs), and ADIPOR1 KO HEK293T cells. This antibody screen revealed that only five of these reagents could
detect exogenous ADIPOR1 while only one antibody (IBL - ADIPOR1) could detect the endogenous protein as
determined by the antibody’s ability to detect a protein of the predicted molecular weight in the WT but not KO
samples (Fig. 1a, Supplementary Fig. 2, Table S1). Using this identified antibody, we then re-tested the heat sensitivity of the endogenous ADIPOR1 protein and found that like its transfected version and similar to other membrane proteins15,16, it was also highly vulnerable to heat as even 1 minute at 95 °C strongly reduced the detected
signal (Supplementary Fig. 1).
Next, we wanted to test this antibody for its ability to detect endogenous ADIPOR1 from tissue samples as well
as to look at ADIPOR1 protein distribution. A western blot of different mouse tissues, including a WT and KO
mouse eye control, revealed successful antibody detection of the endogenous ADIPOR1 protein as well as a strong
signal in the eye and the brain, with only faint bands of the predicted weight found in the other analyzed tissues
(Fig. 1b, Supplementary Fig. 3). To further determine if these very low abundance bands were real ADIPOR1 and/
or if ADIPOR1 ran at a different molecular weight in non-central nervous system tissues, as the strongest bands in
these sample lanes were not found in the predicted molecular weight range, we ran WT and KO samples of brain,
liver, muscle, and heart tissues on separate blots. This additional analysis confirmed that ADIPOR1 is indeed
present in the liver, muscle, and heart, but at much lower levels (Fig. 1c, Supplementary Fig. 3).

ADIPOR1 protein is found in the human and mouse neural retina and RPE. Following our western blot profile, we analyzed the expression of ADIPOR1 in the retina by immunohistochemistry (IHC) using
frozen cryosections of three week old WT and KO mice. This analysis confirmed that the IBL antibody was
able to detect ADIPOR1 with IHC and it highlighted that this protein is present in the retina with the strongest
signal appearing in the photoreceptor outer segments (OS). Weaker signal intensity appeared in the rest of the
neural retina including the outer nuclear layer (ONL), and unlike a previous report7, the RPE (Fig. 2). Following
the determination of ADIPOR1 expression in the mouse retina, we wanted to compare this profile with human
expression. First, we performed in situ hybridization (ISH) for mRNA levels of ADIPOR1 in the human retina
using RNAscope (Supplementary Fig. 4). This analysis showed ADIPOR1 mRNA presence throughout the neural
retina and the RPE. We then performed IHC on paraffin-embedded sections of human retinas to test for protein
expression of ADIPOR1 and observed a surprising enrichment of ADIPOR1 only on the apical side of the RPE
layer (Supplementary Fig. 4). To confirm whether ADIPOR1 protein was truly absent from the neural retina or
whether the antibody was less adapt at detecting paraffin embedded epitopes, we performed western blotting
on separately dissected human eye samples of neural retina and posterior eye cup that contains the RPE layer.
Blotting for RPE65 and RHODOPSIN, as markers of the RPE and the photoreceptors/neural retina, respectively,
we confirmed that the retinal layers were indeed separated in these samples and ADIPOR1 protein was found in
both layers (Supplementary Fig. 4).
AdipoR1 KO mice are largely normal at two weeks but have a compromised visual system by
three weeks of age. Since the previous AdipoR1 KO study had shown subtle retinal degeneration but pro-

found loss of ERGs in 3–4 week old animals, we wondered how the expression of visual system proteins was
affected at this early stage prior to pronounced photoreceptor loss5. First, we looked at RHODOPSIN levels in
AdipoR1 KO eyes at postnatal day 22 (P22) by western blot. This analysis highlighted a surprisingly sharp loss of
RHODOPSIN at this early age (Fig. 3a,b) in the KO but not the HET or WT samples. Then we profiled the eyes
SCIeNTIfIC Reports | (2018) 8:14339 | DOI:10.1038/s41598-018-32579-9
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Figure 1. ADIPOR1 protein expression in mouse tissues. (a) Anti-ADIPOR1 antibody (IBL) can recognize
endogenous and exogenous ADIPOR1. Lanes: 1 – Flag-ADIPOR1 transfected HEK293T, 2 – WT/Untransfected
HEK293T, 3 – CRISPR negative control transfected HEK293T, 4 – ADIPOR1 KO HEK293T clone 4,
ADIPOR1 KO HEK293T clone 5. Anti-Flag antibody (CST) was used to detect exogenous tagged ADIPOR1.
CYCLOPHILIN B was used as a loading control. (b) ADIPOR1 protein expression profile from different tissues.
Adult mouse tissues and P22 mouse eye tissue were profiled. ADIPOR1 is enriched in the eye and brain. The
antibody retains specificity in tissue samples as based on WT and KO eye tissue discrimination. (c) ADIPOR1
protein is present in non-nervous tissues. ADIPOR1 protein signal can be appreciated in liver, heart, and
skeletal muscle when ran without brain or eye samples, confirming protein presence in those tissues. Four and
a half month old AdipoR1 WT and KO mice were used for tissue collection. Each lane represents a sample from
an individual mouse. VINCULIN was used as a loading control. For (a) and (c) each membrane was cut and
probed separately for the analyzed protein and the loading control.

for levels of CRX, a photoreceptor transcription factor whose levels would be indicative of ONL thinning rather
than OS shortening. The levels of CRX were statistically normal, however, supporting the prior data that the ONL
is still largely intact at this age5. Next, we further profiled two OS-associated structural proteins, PERIPHERIN-2
and ROM1, and found the levels of both to be significantly decreased in the KO eyes, suggesting that the OS in
three week old AdipoR1 KO animals are compromised. Additionally, we looked at the levels of three proteins
involved in vision, RPE65, PDE6α, and GNAT1, and detected a significant drop in levels of PDE6α and GNAT1
and a downward trend in RPE65, demonstrating that the rest of the visual cascade is also negatively compromised
in the KO animals.
We wondered if the visual system was disturbed even earlier and profiled most of the proteins from our P22
profile again using P15 mouse eyes. With the exception of a small decrease in RPE65, none of the other profiled
proteins reached a statistically significant decrease at this younger age (Fig. 4a,b), suggesting that retinal degeneration begins later than P15 in these animals. Additionally, apart from a slight increase of PDE6α in the P22 HETs,
the protein levels of both WT and HET samples at P15 and P22 showed mostly equal levels, indicating that half of
the normal ADIPOR1 expression is sufficient for retinal stability.

ADIPOR1 loss in photoreceptors or RPE of adult animals decreases expression of markers critical for vision. After determining that ADIPOR1 is necessary for the visual system since its absence during
development results in retinal degeneration and early-onset blindness, we wondered if ADIPOR1 is also needed
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Figure 2. ADIPOR1 is expressed in the neural retina and RPE. IHC for ADIPOR1 protein expression. P21
mouse eyes of AdipoR1 WT or KO genotypes were stained with the anti-ADIPOR1 antibody (IBL). ADIPOR1
signal is observed in the neural retina and the RPE with strongest expression in the OS. Scale bar = 20 µm.
Z-stacks were acquired and the maximum intensity projection is displayed.
post-development in adult animals and whether it is needed in both photoreceptors and the RPE. We generated
AAV-Cre viruses where Cre is driven by a (1) constitutive CMV promoter, (2) VMD2 (aka BEST1), an RPE specific promoter, or (3) IRBP, a photoreceptor specific promoter. Then we injected these AAVs subretinally into
the eyes of nine month old WT or floxed AdipoR1 mice that would lose their ADIPOR1 protein expression upon
Cre-induced recombination.
To assess any retinal damage stemming from AAV-Cre induced ADIPOR1 loss, we measured retinal thickness close to the site of virus injection using optical coherence tomography (OCT) at one and three months post
injection (Supplementary Fig. 5). At both time points, no statistically significant difference was reached for retinal
thinning between WT and floxed injected animals, a comparison that would be indicative of retinal thinning
arising due to ADIPOR1 loss alone.
However, retinal thinning was observed in the injected animals when compared to naïve (uninjected) animals,
with the largest decrease observed in the CMV-Cre and VMD2-Cre treated floxed groups at three months post injection. Yet, this decrease occurred in both WT and floxed animals, likely due to Cre toxicity17,18, thus we could not
verify the role of ADIPOR1 loss based on OCT data alone. Since our OCT analysis only evaluated a relatively minor
region of the retina near the injection site, where Cre overexpression-induced death would likely be strongest, we
decided to analyze the whole mouse eyes to look for effects of the KO on a larger area. To determine whole eye effects
we analyzed retinal cell marker protein expression in the injected mice at 5 months post injection by western blot.
First, we tested the levels of RHODOPSIN and CRX in whole eyes from naïve control age-matched litters
and observed equal RHODOPSIN and CRX levels between WT and floxed animals with little sample-to-sample
variability (Supplementary Fig. 6). Then we tested the CMV-Cre, IRBP-Cre, and VMD2-Cre treated animals for
ADIPOR1, RHODOPSIN, CRX, RPE65, GNAT1, and IRBP (Fig. 5a,b, Supplementary Figs 7, 8 and 9). Unlike the
naïve control mice, western blots of the AAV-Cre treated mice showed much more variable RHODOPSIN and
CRX levels. For the CMV-Cre group, we observed a 37% decrease for ADIPOR1 in the floxed animals compared
to WT controls supporting Cre-induced KO (Supplementary Fig. 7). However, despite a downward trend for
floxed vs WT samples, blots for RHODOPSIN, CRX, GNAT1, and IRBP did not show a statistically significant
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Figure 3. Three week old AdipoR1 KO mice exhibit deficient expression of visual system proteins. (a) Western
blots of P22 AdipoR1 WT, HET, and KO mouse eyes are shown. ADIPOR1 as well as known visual system proteins
were profiled. VINCULIN was used as a loading control. Each lane represents a sample from an individual mouse,
n = 3. KO mice exhibit reduced levels of RHODOPSIN, PERIPHERIN-2, ROM1, PDE6α, and GNAT1. Each
membrane was cut and probed separately for the analyzed protein and the loading control. (b) Densitometry
quantification of western blots in (a). ANOVA (α = 0.05) with Dunnett’s multiple comparisons test (WT set as
control) was used. Error bars represent standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001,
NS = not significant. P values: ADIPOR1, WT vs HET p = 0.0409, WT vs KO p = 0.0008; CRX = WT vs HET
p = 0.0811, WT vs KO p = 0.3451; PDE6α, WT vs HET p = 0.0045, WT vs KO p = 0.0001; RHODOPSIN = WT
vs HET p = 0.2541, WT vs KO p = 0.0058; GNAT1 = WT vs HET p = 0.0706, WT vs KO p = 0.0298; RPE65 = WT
vs HET p = 0.4107, WT vs KO p = 0.2346; PERIPHERIN2 = WT vs HET p = 0.4984, WT vs KO p = 0.0473;
ROM1 = WT vs HET p = 0.0825, WT vs KO p = 0.0409.
difference between the two genotypes. Nevertheless, the levels of RPE65 were significantly decreased in the floxed
mice as compared to WT controls. The western blot analysis of the IRBP-Cre and VMD2-Cre treated animals
showed more statistically significant differences that further supported the hypothesis that AdipoR1 KO leads to
a decrease in expression of markers critical for vision in adult animals.
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Figure 4. Two week old AdipoR1 KO mice appear normal. (a) Western blots of P15 AdipoR1 WT, HET, and
KO mouse eyes are shown. ADIPOR1 as well as known visual system proteins were profiled. VINCULIN was
used as a loading control. Each lane represents a sample from an individual mouse, n = 7 for WT, n = 8 for HET,
n = 8 for KO. KO mice appear normal except for a possible decrease of RPE65. Each membrane was cut and
probed separately for the analyzed proteins and the loading control. (b) Densitometry quantification of western
blots in (a). ANOVA (α = 0.05) with Dunnett’s multiple comparisons test (WT set as control) was used. Error
bars represent standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, NS = not significant.
P values: ADIPOR1, WT vs HET p = 0.0001, WT vs KO p = 0.0001; RPE65, WT vs HET p = 0.9917, WT vs
KO p = 0.0261; RHODOPSIN, WT vs HET p = 0.8916, WT vs KO p = 0.8314; PERIPHERIN2, WT vs HET
p = 0.3510, WT vs KO p = 0.3317; PDE6α, WT vs HET p = 0.3728, WT vs KO p = 0.7756; GNAT1, WT vs HET
p = 0.5035, WT vs KO p = 0.9541.

For the IRBP-Cre treated group, which appeared less variable than the CMV-Cre group reviewed above,
western blot analysis showed a 47% decrease in ADIPOR1 for the floxed animals vs WT controls (Fig. 5a,
Supplementary Fig. 8). The levels of RHODOPSIN and RPE65 were also statistically significantly decreased in
SCIeNTIfIC Reports | (2018) 8:14339 | DOI:10.1038/s41598-018-32579-9
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Figure 5. AAV-Cre treated adult floxed mice show decreased expression of markers critical for vision. (a) Western
blot for RHODOPSIN of IRBP-Cre treated mouse eyes is shown. VINCULIN or α-TUBULIN was used as a
loading control. Each lane represents an individual eye from a mouse of that genotype, n = 10 for WT, n = 14
for Floxed. Densitometry quantification for RHODOPSIN and additional western blots (see Supplementary
Fig. 8) is shown below. IRBP-Cre treated mice show a large drop in ADIPOR1, confirming Cre induced KO of
this protein. These mice also display a significant drop of RHODOPSIN and RPE65. IRBP group - P values:
ADIPOR1 - p = < 0.0001; RHODOPSIN - p = 0.0033; CRX - p = 0.0512; RPE65 - p = 0.0009; GNAT1 - p = 0.2680;
IRBP - p = 0.0570. (b) Western blot for RHODOPSIN of VMD2-Cre treated mouse eyes is shown. VINCULIN or
α-TUBULIN was used as a loading control. Each lane represents an individual eye from a mouse of that genotype,
n = 10 for WT, n = 11 for Floxed. Densitometry quantification for RHODOPSIN and additional western blots
(see Supplementary Fig. 9) is shown below. VMD2-Cre treated mice show a small drop in ADIPOR1 consistent
with a KO of this protein only in the RPE layer. These mice also display a significant drop of RHODOPSIN, CRX,
GNAT1, and IRBP. VMD2 group - P values: ADIPOR1 - p = 0.0080; RHODOPSIN - p = 0.0092; CRX - p = 0.0093;
RPE65 - p = 0.3471; GNAT1 - p = 0.0087; IRBP - p = 0.0442. Unpaired two tailed t-test was used. *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001, NS = not significant. Error bars represent standard deviation. Mice
were taken down at 5 months post AAV injection. For western blots in (a,b) each membrane was cut and probed
separately for the analyzed protein and the loading control.
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the floxed mice. The levels of CRX, GNAT1, and IRBP were not significantly decreased though, suggesting that
despite a loss of RHODOPSIN, the photoreceptors had not yet succumbed to cell death which is consistent with
the OCT data showing no significant retinal thinning of IRBP-Cre treated vs naïve mice. In the VMD2-Cre treated
group, we detected the smallest decrease of ADIPOR1 for the floxed vs WT animals, only 11%, consistent with
the cell-type specific KO of AdipoR1 in the RPE cells alone (Fig. 5b, Supplementary Fig. 9). However, despite the
smaller loss of ADIPOR1, VMD2-Cre treated floxed animals demonstrated a statistically significant decrease in
five of the six proteins we analyzed: ADIPOR1, RHODOPSIN, CRX, GNAT1, and IRBP.

ADIPOR1 RPE expression is diminished in the Mfrprd6 mouse. The molecular function of ADIPOR1
in the retina is currently unclear. To identify potential pathways affected by ADIPOR1, we examined the Mfrprd6
mouse9. Retinal phenotypes in the Mfrprd6 mice are similar to those observed in the AdipoR1 KO. Both develop a
flecked retina fundus appearance, accumulate subretinal macrophages, exhibit ONL thinning starting at approximately 1 month of age, and show diminished ERGs before significant photoreceptor loss9,19,20. Additionally, like
ADIPOR1, MFRP has been reported to be expressed on the apical side of the RPE layer in mice9 and we have
observed this same expression pattern in the human retina (Supplementary Fig. 4). Due to these similarities, we
wondered if ADIPOR1 expression was perturbed in the absence of MFRP or vice versa. First, we performed IHC
on AdipoR1 WT, HET, and KO mouse retinas for MFRP and detected equally enriched apical RPE expression for
all genotypes (Supplementary Fig. 10). Then, we performed IHC for ADIPOR1 on Mfrprd6 retinas and observed a
striking loss of ADIPOR1 signal specifically in the RPE layer (Fig. 6a). Western blotting for ADIPOR1 expression
in Mfrprd6 mouse eyes showed that at P21, an age with little to no ONL thinning20, ADIPOR1 is dramatically
decreased (Fig. 6b). We also took greater notice of the ADIPOR1 doublet running pattern on a western blot.
Notably, the top fainter band of ADIPOR1 appeared to be missing in the Mfrprd6 mouse eyes. We probed this
running pattern further by comparing a whole mouse eye, human stem cell-derived RPE cells, and HEK293T
cell lysate side by side and saw that the RPE and HEK293T ADIPOR1 tends to run higher than the darker mouse
eye band (Fig. 6c), suggesting that the missing top band in Mfrprd6 eyes represents the loss of ADIPOR1 in their
RPE layer.
RNA-seq profile of AdipoR1 KO model mice identifies an increase in Irbp levels at P15. In order
to assess whether a particular signaling pathway may be perturbed in the absence of ADIPOR1, we analyzed
gene expression in P15 and P22 AdipoR1 WT, HET, and KO mouse eyes by RNA-sequencing. At P22, we found
more than 3300 differentially expressed genes between WT and KO samples, while at P15 only 50 were significantly different. At P22, this gene expression analysis highlighted downregulation of visual system pathways and
upregulation of inflammatory and immune system markers (Supplementary Table S2). However, in the P15 gene
expression dataset, we surprisingly found that Irbp was the most significantly upregulated gene in the AdipoR1
KO eyes as compared to WT or HET mice. This Irbp upregulation decreased at P22, but still persisted on the
mRNA level. We then confirmed this IRBP increase on the protein level in P15, but not P22, AdipoR1 KO mouse
eyes (Fig. 7a–c). We wondered if this IRBP increase would also be present in the Mfrprd6 mouse eyes and checked
a previously published microarray dataset21, but found no upregulation there. Yet, on the protein level we found
that Mfrprd6 P15 mouse eyes exhibit a significant increase in IRBP. Like the AdipoR1 KO, by P21 IRBP protein levels in the Mfrprd6 mouse eyes were similar to their cohort controls (Fig. 7d–f). Moreover, the spatial distribution
of IRBP in the interphotoreceptor matrix was disrupted in the AdipoR1 KO retinas when observed at P15 and P21
(Fig. 8). In WT retinas, IRBP was localized primarily to the OS with much lower expression in the inner segments
(IS). However, in AdipoR1 KO retinas strong IRBP signal was evenly dispersed between the IS and the OS, with
no space of low signal between the OS and the ONL.

Discussion

When ADIPOR1 and ADIPOR2 were first identified as the receptors for the metabolic hormone adiponectin1,
these proteins generated much interest in the diabetes field with regards to their potential ability to mediate adiponectin effects on insulin response3,22,23. However, the role of ADIPOR1 and ADIPOR2 in controlling adiponectin effects has remained controversial due to the conflicting phenotypes observed in KO mouse models of these
receptors. One published study observed a predisposition to the development of insulin resistance and diabetes
for both KO models3, while another reported no insulin resistance in the AdipoR1 KO and an inverse protective
effect for the AdipoR2 KO4 that was also observed by two other independent groups24,25. In the latter of these
studies, AdipoR1 KO mice were also shown to have normal insulin levels when fed a standard diet and they did
not recapitulate an impaired ischemic revascularization phenotype observed previously in adiponectin-deficient
mice25. Additionally, in a recent study of ADIPOR1 overexpression in pancreatic β-cells of WT or Akita mice,
ADIPOR1 did not increase insulin secretion, reduce blood glucose, or improve β-cell survival26, an ascribed
property of adiponectin27–29. Furthermore, although there have been reports of human ADIPOR1 single nucleotide polymorphisms (SNPs) associated with diabetes and insulin resistance30–32, there have also been a number of
opposing studies finding no such relationship8,33–37, while yet another group failed to validate a previously identified insulin sensitivity-associated SNP but did detect a distinct relationship between this SNP and olfaction38,39.
In addition to these inconsistencies with regards to the metabolic contributions of ADIPOR1 mutations, the
AdipoR1 KO has also been shown to cause retinal degeneration in mice, which was not observed in the adiponectin KO5. Moreover, this retinal degeneration phenotype was also observed in a zebrafish model of ADIPOR1 loss7,
and two novel human mutations in ADIPOR1 have been identified that cause retinitis pigmentosa6,7, while
ADIPOR1 mutations causing metabolic dysfunction are still lacking.
Perhaps adding to these dissonant results, is the sole reliance on mRNA levels to determine the expression
pattern of these receptors1,39,40 as well as the many non-specific anti-ADIPOR1 antibodies used by researchers.
Expression of mRNA should be considered carefully because its levels do not correlate well with protein levels11,12,
SCIeNTIfIC Reports | (2018) 8:14339 | DOI:10.1038/s41598-018-32579-9
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Figure 6. Mfrprd6 mice lack ADIPOR1 in their RPE layer. (a) IHC on P32 Mfrpwt and Mfrprd6 mouse eyes.
Anti-ADIPOR1 staining was performed on Mfrpwt controls and Mfrprd6 mouse eyes. Anti-MFRP staining below
confirms genotypes. Inset shows enlarged image near RPE layer. ADIPOR1 signal is lost in the RPE of Mfrprd6
animals. ADIPOR1/MFRP is observed via the red reaction product. Scale bar = 20 µm. (b) Western blot for
ADIPOR1 using Mfrpwt and Mfrprd6 mouse eyes of age P21. α-TUBULIN was used as a loading control. Each
lane represents an eye from a mouse of that genotype and eyes were loaded in pairs from individual animals (5
Mfrpwt and 5 Mfrprd6 individual animals), n = 10 eyes for both genotypes. The membrane was cut and probed
separately for the analyzed protein and the loading control. Below, a zoomed in image of lanes 8–13 highlights
the absence of the top ADIPOR1 band from the Mfrprd6 animals. (c) Western blot for ADIPOR1 comparing
samples from a mouse eye, human stem cell derived RPE, and HEK293T cells. RPE and HEK293T ADIPOR1
runs at the same molecular weight as the top band from the mouse eye ADIPOR1 doublet. RPE cells were
derived from H9 hESCs and matured for three months before analysis.
especially when comparing different tissues13, and antibodies need to be rigorously validated41. Our antibody profile revealed that despite a number of anti-ADIPOR1 antibodies appearing in published studies, only one of these
reagents could detect the endogenous protein. After identifying this specific anti-ADIPOR1 antibody, we profiled
different mouse tissues for protein expression and found that unlike the previously reported ubiquitous mRNA
expression pattern of ADIPOR1 with particularly high skeletal muscle abundance1, the protein distribution of
ADIPOR1 was much closer to a recent qRT-PCR dataset7, with dramatic enrichment of this protein in the eye and
brain and a relative paucity of this protein in the skeletal muscle, liver, pancreas, or adipose tissue. The combination of this protein expression profile, lack of retinal degeneration in adiponectin KO mice, and the identification
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Figure 7. AdipoR1 KO mice and Mfrprd6 mice have an upregulation of IRBP at 2 weeks of age. (a) Western blot
of P15 AdipoR1 WT, HET, and KO mouse eyes is shown. α-TUBULIN was used as a loading control. Each lane
represents a sample from an individual mouse, n = 7 for WT, n = 8 for HET, n = 8 for KO. (b) Western blot of
P22 AdipoR1 WT, HET, and KO mouse eyes is shown. α-TUBULIN was used as a loading control. Each lane
represents a sample from an individual mouse, n = 3. (c) Densitometry quantification of blots from (a,b). (d)
Western blot of P15 Mfrpwt or Mfrprd6 mouse eyes is shown. α-TUBULIN was used as a loading control. Each
lane represents a sample from an individual mouse, n = 7 for Mfrpwt, n = 7 for Mfrprd6. (e) Western blot of P21
Mfrpwt or Mfrprd6 mouse eyes is shown. α-TUBULIN was used as a loading control. Each lane represents an eye
from a mouse of that genotype and eyes were loaded as pairs from individual animals (5 Mfrpwt and 5 Mfrprd6
individual animals), n = 10 eyes for Mfrpwt and n = 9 for Mfrprd6 (one eye was excluded due to low protein
levels). (f) Densitometry analysis of blots from (d,e). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001,
NS = not significant. ANOVA (α = 0.05) with Dunnett’s multiple comparisons test (WT set as control) was
used in (c). Unpaired two tailed t-test was used in (f). Error bars represent standard deviation. P values: for part
(c). IRBP P15 AdipoR1: WT vs HET - p = 0.9940, WT vs KO - p = 0.0001. IRBP P22 AdipoR1: WT vs HET p = 0.0714, WT vs KO - p = 0.2560. For part (f). IRBP P15 Mfrprd6: p < 0.0001, IRBP P21 Mfrprd6 p = 0.8777.
For all western blots, each membrane was cut and probed separately for the analyzed protein and the loading
control.
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Figure 8. IRBP is mislocalized in the AdipoR1 KO mice. IHC of P15 and P21 mouse eyes of AdipoR1 WT or KO
genotypes were stained with the anti-IRBP antibody. IRBP is localized primarily to the OS in WT animals. In
AdipoR1 KO retinas IRBP signal appears evenly distributed between the IS and OS. Scale bar = 20 µm. Z-stacks
were acquired and the maximum intensity projection is displayed.

of human ADIPOR1 blindness causing mutations makes a compelling argument for ADIPOR1 playing a stronger
role in vision biology rather than in its more commonly proposed role in glucose metabolism.
When we explored the retinal phenotype of AdipoR1 KO mice further, we found a number of surprising attributes. Histological and western blot analysis of protein expression in mouse and human retina tissues revealed
that ADIPOR1 is expressed throughout the neural retina and the RPE with enriched expression in the OS. This
contrasts with a previous report7 that utilized an anti-ADIPOR1 antibody that was invalidated in our study.
Additional profiling of P15 and P22 AdipoR1 WT, HET, and KO mouse eyes revealed decreased visual system
proteins in the KO mice. While two week old KO animals were ostensibly normal, three week old KO animals
exhibited significant retinal dystrophy as they were almost completely depleted of RHODOPSIN and displayed
much lower amounts of two structural OS proteins and two phototransduction proteins.
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A reduction of these key light perception components would likely explain the highly attenuated ERGs as well
as the decrease of DHA, a highly OS-enriched poly-unsaturated omega-3 fatty acid42, previously measured in
AdipoR1 KO mice at 3–4 weeks of age5. Although it is possible that ADIPOR1 still contributes to DHA uptake or
retention, past studies of dietary DHA deficiency have reported decreased retinal sensitivity based on ERG measurements43–45, but no photoreceptor loss as occurs in the AdipoR1 KO model. Additionally, the KO of Mfsd2a,
a major DHA transporter in the eye46 and brain47, results in drastic DHA reduction in the retina but its retinal
degeneration phenotype is much less severe than that of the AdipoR1 KO as four month old Mfsd2a KO mice
display only minor ONL thinning and have no significant reduction in ERGs46.
In addition to expanding on the previously reported5 vital role of ADIPOR1 in the retina of young animals,
we also showed that this protein is needed in adult animals. We administered AAV-Cre driven by either a photoreceptor or an RPE specific promoter to nine month old WT or floxed AdipoR1 mice subretinally and observed
statistically significant reduction in proteins critical for vision. Notably, although the photoreceptor-specific KO
of AdipoR1 resulted in a greater loss of ADIPOR1 compared to mice treated with the RPE promoter AAV, we
detected a decrease of more retinal markers in the RPE-Cre treated group, suggesting a more essential role for
ADIPOR1 in this cell type. We gained further support for a hypothesis of an essential ADIPOR1 RPE function by examining the Mfrprd6 mouse, a mouse model of an Mfrp KO with striking similarities to the AdipoR1
KO9,19,20. Remarkably, we found an absence of ADIPOR1 expression in the RPE layer of Mfrprd6 mice compared
to littermate controls, while ADIPOR1 in the adjacent photoreceptors was still present. These results suggest that
analogous to our AAV-Cre RPE-specific AdipoR1 KO, retinal degeneration observed with Mfrp mutations may
actually be due to an RPE deficiency of ADIPOR1. Importantly, much like the recent ADIPOR1 reports6,7, MFRP
mutations are also known to cause retinitis pigmentosa in human patients48–50 and it will be instrumental to
assess whether their disease is caused by ADIPOR1 loss and whether it can be prevented via rescue of ADIPOR1
expression.
When we further analyzed Mfrprd6 eyes by western blotting, we observed that while whole WT eyes displayed a distinct doublet of ADIPOR1 signal, Mfrprd6 eyes appeared to only have a single band. An additional
comparison of this whole mouse eye ADIPOR1 running pattern to a pure RPE sample showed that the signal
doublet can be broken down into a top RPE band and bottom non-RPE band, likely representing the neural
retina. Importantly, congruent to our IHC results, Mfrprd6 eyes were missing only the top band, the inferred RPE
signal. We also noticed slightly different ADIPOR1 running patterns in the other mouse tissues: a single band in
the brain, heart, and skeletal muscle, and distinct doublets in the eye and liver. We speculate that these differences
are either splice isoforms of AdipoR151 or post-translational modifications that may modify ADIPOR1 function.
However, the mouse genome does not contain alternative transcripts encoding a protein of a different molecular
weight and of the four predicted human protein coding transcripts only the canonical encoded protein sequence
is predicted to run near the molecular weight we observed (Ensembl genome browser 91, December 2017)52. It
will be intriguing to ascertain whether these seemingly different forms of ADIPOR1 do indeed modify its function leading to distinct molecular properties.
In an effort to better understand the mechanism of AdipoR1 KO induced retinal degeneration, we performed
RNA-sequencing analysis in two and three week old animals. While the three week old animals highlighted many
known gene expression changes that have been observed in a number of other retinal degeneration models53–55,
namely a downregulation in visual perception pathways and an upregulation in inflammation and immune system response genes, as would be expected if the photoreceptors were starting to die at this age, we were surprised
to detect a unique conspicuous feature of the AdipoR1 KO at two weeks of age – an upregulation of Irbp, a gene
that encodes a key retinoid transport protein produced and secreted exclusively by photoreceptors. We confirmed
this IRBP upregulation on the protein level in two week old animals, and found that similar to the observed
mRNA changes, IRBP was reduced back to normal levels at three weeks of age. Intriguingly, protein analysis of
Mfrprd6 mice showed the same IRBP expression pattern with an early peak followed by normalization. Notably,
Irbp KO mice exhibit progressive retinal degeneration56 and multiple animal models of retinal degeneration have
also observed a decrease in IRBP expression57–59, therefore the sharp increase in this protein in a retinal degeneration model is surprising. However, one other retinal degeneration model has been described where an increase
in IRBP was also detected, the vitiligo mouse model60–62. Similarly to the AdipoR1 KO and Mfrprd6, vitiligo mice
develop a progressive retinal degeneration accompanied by an increase in IRBP protein levels60 as well as an
IRBP mislocalization63 from the OS to the IS that we also observed. Due to this phenotypic mimicry and since
the vitiligo mouse model appears to have a dysfunction in retinoid metabolism60,64, this data presents an exciting hypothesis for whether ADIPOR1 functions to control retinoid levels as well. Additionally, recent data has
demonstrated that ADIPOR1 is likely a ceramidase28,65,66 and ceramide signaling has been proposed to function
in maintaining photoreceptor survival in flies, mice, and humans67. Moreover, another enzyme, dihydroceramide
desaturase-1 (DES1), has also recently been reported to function as a retinol isomerase in the cone visual cycle68,
suggesting that at least one other enzyme can have activity on both, ceramides and retinoids. Taken together, the
enrichment of ADIPOR1 in the retina combined with its retinitis pigmentosa causing mutations, described ceramidase activity, and dysregulation of IRBP, appears to point toward a pivotal role in the visual cycle that requires
further exploration.

Materials and Methods

All experiments used whole eyes unless otherwise indicated.

Animals.

All procedures and housing conditions were approved and performed as described in the associated Novartis Cambridge Institutional Animal Care and Use Committee protocol. AdipoR1 KO (B6;129S5
Adipor1 <tm1.2Lex>) and floxed (B6;129S5 Adipor1 < tm1.1Lex>) mice were purchased from Taconic
Biosciences (Germantown, NY). Mouse breeding was set up as a HET by HET mating to reduce the chance of
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any maternal effects arising from the AdipoR1 KO. Genotyping was assessed by PCR according to Taconic recommendations. Primers 5′-CAGGCTGGCCTCGAGTTCAG-3′ and 5′-ATGGACAAATTCCTTGGCAAG-3′
were used to amplify a 370 bp KO band and primers 5′-CAGGCTGGCCTCGAGTTCAG-3′ and
5′-GCCAGCTCCACTGTGTCAGC-3′ were used to amplify a 389 bp WT band. A KO genotype was confirmed
by presence of the KO band alone, WT genotype produced WT band alone, HETs produced a KO and a WT band.
All breeder mice were tested and confirmed to be negative for the rd1 and rd8 mutations. Mixed gender mice were
used for all experiments.
Mfrprd6 (B6.C3Ga- Mfrprd6/J, Stock No. 003684) and control B6 (C57BL/6 J, Stock No. 000664) (WT) mice in
this study were bred and maintained in standardized conditions of the Production and Research Animal Facilities
at The Jackson Laboratory (JAX). They were provided with a NIH31 6% fat chow diet and acidified water, in a
pathogen-free vivarium environment with a 14-hour light/10-hour dark cycle. All experiments were approved by
the Institutional Animal Care and Use Committee and conducted in accordance with the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research.

OCT imaging. Retinal images were acquired using a spectral domain optical coherence tomography system (Envisu R-Class, Bioptigen, Morrisville, NC). Images were acquired approximately one week after injection to exclude any eyes with substantial complications from the injection procedure. OCT imaging for retinal
thickness assessment occurred at 4 and 13 weeks post-injection. Prior to the OCT procedure, animals were
anesthetized with IP ketamine/xylazine cocktail and received 1.0% cyclopentolate and 2.5–10% phenylephrine
topically for dilation in addition to 0.5% proparacaine as a topical anesthetic. Animals were placed on a heating
pad during image acquisition and eye hydration was maintained with topical application of mild to moderate
GenTeal drops (Novartis). A high quality image of the retina was generated by aligning and averaging 20 horizontal (nasal-temporal) b-scans centered on the optic nerve. Scans were 1.7 mm in length and consisted of 1000
a-scans/b-scan. Image co-registration and averaging was performed using MATLAB (Mathworks, Natick, MA).
A custom algorithm in MATLAB was subsequently used to manually delineate the inner limiting membrane and
the basal RPE at Bruch’s membrane. Retinal thickness was reported as the average distance between the two lines
across the visible portion of the retina with the exception of the central 340 μm of the b-scan that was excluded
due to variable retinal thickness near the optic nerve.
AAV virus generation and subretinal injection.

AAV expression plasmids encoding GFP-Cre driven
by either CMV, human VMD269, or human IRBP70 were generated to express Cre constitutively, in the RPE69, or
in photoreceptors70, respectively. AAV vectors were produced at the University of Massachusetts Medical School
Gene Therapy Center and Vector Core using these plasmids. The CMV-GFP-Cre construct was packaged into
AAV serotype 1 while the VMD2 and IRBP constructs were packaged into AAV serotype 2. AAV Cre activity was
confirmed in HEK293-loxP-GFP-RFP (Cat#: SC018-Puro, GenTarget Inc). Both eyes of 9 month old animals were
injected subretinally as previously described71 at a dose of 1 × 10^9 genome copies per eye. Mice were taken down
5 months post injection for dissection and western blot analysis. Floxed B6;129S5 Adipor1 <tm1.1Lex> mice of
either WT or unexcised KO were injected. Uninjected animals served as naïve age matched controls.

Human tissues preparation.

All human samples were collected with the approval of the Novartis HTN
(human tissue network), following the guidance of OPH HTN with informed consent from all donors. Human
eye tissues were fixed at room temperature with Modified Davidson’s Fixative for two days and followed by 70%
ethanol for another two days. After fixation, the tissues were processed and embedded in paraffin. The paraffin
embedded eye sections were cut at 5 µm and used for ADIPOR1 mRNA detection and the expression of ADIPOR1
and MFRP proteins. For western blotting, unfixed human eye tissue was dissected and frozen prior to lysis.

In situ hybridization – RNAscope.

®

Visualization of ADIPOR1 transcript variant 1 mRNA (RNAscope
2.5 LS Probe - Hs-ADIPOR1 (Cat# 472298, ACD) was done in Automated Leica Bond RX according to manufacturer’s instruction for RNAscope 2.5 LS (Advanced Cell Diagnostics, Newark, CA, USA). RNAscope has
been shown to be capable of single mRNA molecule detection. The positive control probe consisted of a proprietary probe for POLR2A (Cat# 310458), while the negative control probe targeted dapB of Bacillus subtilis (Cat
# 312038).

®

®

Immunohistochemistry. Human samples. Detection of ADIPOR1 and MFRP proteins was done in
Automated Leica Bond RX. Anti-ADIPOR1 antibody (Cat# 18993, IBL) was applied at 1:50 dilution and detected
by Bond Polymer Refine Red Detection (Leica Biosystems, Cat# DS9390); anti-MFRP antibody (Cat # AF1915,
R&D Systems) was applied at 1:1000 dilution and detected by Bond Polymer Refine Detection (Cat # DS9713,
Leica Biosystems) with Vina GreenTM Chromogen (Cat # BRR807A, Biocare Medical).
Mouse samples. AdipoR1 mouse model whole eyes of age P15 or P21 were harvested and immersed in ice cold
3.2% PFA made in PBS (pH = 7.4) for 30 minutes. The eyes were washed with PBS and left in cryoprotective
solution (20% sucrose in PBS) overnight at 4 °C and then embedded in OCT (Optimal Cutting Temperature
compound, Cat # 62550-01, Electron Microscopy Sciences) and frozen. Frozen cryosections were cut at 10-16
μm thickness. Sections were blocked with 10% Normal Goat Serum (NGS, Cat # 5425, Cell Signaling Technology,
Danvers, MA) with 0.01% Triton-X-100 in PBS for 1 hour at RT. Primary antibodies were diluted in 10% NGS,
0.01% Triton-X-100, PBS and incubated with the sections overnight at RT in a humidified chamber. Sections were
washed with PBS and incubated with the secondary antibody (Goat anti-Rabbit Alexa-647 at 1:1000 dilution, Cat
# A-21245, Thermo Fisher Scientific) for 45 minutes at RT in 10% NGS, 0.01% Triton-X-100, PBS. After secondary antibody washing, sections were stained with Hoechst 33342 (1:10,000 dilution, Cat # H3570, Thermo Fisher
Scientific) for 10 min at RT, washed, and sealed with Aqua-Poly/Mount (Cat # 18606-20, Polysciences, Inc.).
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Fluorescence images were acquired using the LSM 880 confocal microscope with Airy Scan (Zeiss). Exposure
settings for image acquisition were set to KO control levels or no primary controls.
For mouse IHC utilizing paraffin, mouse eyes were collected and fixed in 10% neutral buffered formalin
for 2 days and paraffin embedded, sectioned at 5 μm thickness and mounted onto slides (Superfrost Plus,
Fisher Scientific, Waltham, MA). IHC was performed using the Leica Bond Rx IHC/ISH slide staining system.
Slides were treated by Epitope Retrieval #2 (AR9640) for 20 minutes and incubated with primary antibodies
(anti-ADIPOR1, Cat# 18993, IBL at 1:200 or anti-MFRP, Cat# AF3445, R&D Systems at 1:250) for 30 minutes;
then were incubated with Bond Polymer AP for 20 minutes and Bond Polymer Refine Detection (Ds9800) for
12 minutes. Control sections were only incubated with anti-IgG and stained. Finally, stained slides were covered
and scanned into Aperio AT2 slide scanner (Leica).

®

RNA-sequencing analysis. AdipoR1 WT, HET, and KO whole mouse eyes of age P15 or P22 were collected
and stored in RNAlater Stabilization Solution (Cat # AM7020, Thermo Fisher Scientific) at −80 °C. Four biological replicates were used per genotype of each age (P15 and P22) with both eyes collected for one independent
sample. For RNA extraction, the eyes were thawed and lysed per manufacturer instructions using the RNeasy
Mini Kit (Cat # 74106, Qiagen) with on column DNase I digestion (Cat # 79254, Qiagen). RNA concentration
was measured using Nanodrop 2000 (Thermo Fisher Scientific) and RNA integrity was confirmed using the
Bioanalyzer 2100 (Agilent). RNA-Seq libraries were constructed using a stranded Poly(A) + selection protocol
and sequenced by paired-end chemistry on the Illumina HiSeq. 2500 platform. Technical quality control (QC)
was performed on the RNA-Seq libraries utilizing RNASeQC72. RNA-Seq paired-end short reads were aligned to
the GENCODE mouse reference genome (GRCm38.p4) using STAR (v2.4.1a)73, with default settings. Transcript
quantification was conducted with RSEM (v1.2.22)74, resulting in gene counts and normalized transcripts per
million (TPM). Custom R scripts were used for biological QC and differential gene expression. Specifically, the
edgeR and limma packages were applied to determine significantly differentially expressed genes between experimental groups75. A gene was defined as differentially expressed if it had an adjusted p-value ≤ 0.05.

™

™

Cell culture: HEK293T cells.

®

HEK293T cells (Cat # CRL-3216 , ATCC , Manassas, VA) were maintained
in DMEM/F-12, GlutaMAX (Cat # 10565042) + 10% Fetal Bovine Serum (FBS), certified, heat inactivated (Cat
# 10082147), 1% MEM Non-Essential Amino Acids (Cat # 11140050), 1% Sodium Pyruvate (Cat # 11360070), 1%
Antibiotic-Antimycotic (Cat # 15240062) – all media components were from Thermo Fisher Scientific.
To generate exogenous ADIPOR1 expressing cells, HEK293T cells were plated as 3 million cells per 10 cm
plate the day before transfection, and transfected using 0.5 µg of Flag-ADIPOR1 expression plasmid (Cat
# HG14109-NF, Sino Biological, Beijing, China) using Lipofectamine 3000 (Thermo Fisher Scientific) and
Opti-MEM (Thermo Fisher Scientific). Cells were harvested for lysis 48 hours after transfection.
To generate ADIPOR1 KO and CRISPR control cells, HEK293T were transfected with plasmids encoding
Cas9-2A-Puro + gRNA carrying gRNAs targeting the first coding exon of ADIPOR1 or control gRNAs that were
not predicted to have matches in the human genome.

™

™

ADIPOR1 gRNAs 5′−3′:
GGAAGCTGACACGGTGGAAC
AGCCAGATGTCTTCCCACAA
Non-targeting gRNAs 5′−3′:
GCACTCACATCGCTACATCA
GCACTACCAGAGCTAACTCA
HEK293T cells were plated as 500,000 cells per well of a 6 well plate and transfected with 0.6 µg of total DNA
encoding either two plasmids targeting ADIPOR1 or two non-targeting plasmids (0.3 µg per vector) with 1.2 µL
of P3000 and 5 uL of Lipofectamine 3000 in a mix of 200 µL of total Opti MEM. At 48 hours post transfection, the
cells were selected with 5 µg/mL puromycin for 4 days, a treatment that killed all WT untransfected cells. The KO
cells were then split as single cells using TrypLE Express Enzyme (Cat # 12605036, Thermo Fisher Scientific)
and plated at a low density to form colonies from individual cells. Five of the six picked clones tested negative
for ADIPOR1 by western blotting (Cat # 18993, IBL). Further KO validation was performed by DNA sequencing
(Genewiz, South Plainfield, NJ) of the ADIPOR1 gene on clones 4 and 5 (see Supplementary Fig. 1d, lanes 4 and 5)
and KO was confirmed on the DNA level. These two KO clones were used to profile all anti-ADIPOR1 antibodies.
All HEK293T cells were plated as 3 million per 10 cm plate and expanded for 48 hours before cell lysis.

™

Cell culture: H9-RPE cells. H9 human embryonic stem cells (hESCs -WiCell, Madison, WI) were differentiated to RPE cells using the previously published protocol76 and frozen for future use. To generate H9-RPE cell
lysate, cells were thawed and plated as 5 million cells per well of a 6 well plate in RPE media (RtEGM BulletKit ,
Cat # 00195406 and 00195407, Lonza, Basel, Switzerland). Cells were fed with fresh media daily until they formed
a confluent monolayer and then they were fed with RPE media without FBS every other day for 3 months until
cell lysis for protein analysis.

™

®

Statistical analysis. One-way analysis of variance (ANOVA) (α = 0.05) with Dunnett’s multiple comparisons test (WT set as control) or Tukey’s multiple comparisons test, or an unpaired two tailed t-test were used as
indicated. Statistics were analyzed in GraphPad Prism7.
Western blot.

Cells were lysed with Cell Lysis Buffer (Cat # 9803, Cell Signaling Technology, Danvers, MA)
containing Protease/Phosphatase Inhibitor Cocktail (Cat # 5872, Cell Signaling Technology, Danvers, MA) on ice
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for 30 min with intermittent pipetting. Tissues were lysed in RIPA Buffer (Cat # 9806, Cell Signaling Technology,
Danvers, MA) containing the same Protease/Phosphatase Inhibitor Cocktail. Following dissection, tissues were
placed into lysis buffer on ice, combined with a stainless steel bead (Cat # 69989, Qiagen), and homogenized using
a TissueLyser II (Cat # 85300, Qiagen) in a cold room for 2 min at a frequency of 30 Hz. Following homogenization, tissue samples were briefly sonicated (XL-2000, Misonix). Upon lysis completion, cell and tissue lysate was
centrifuged at 20,000xg for 25 min at 4 °C. The soluble fraction was kept for further analysis and quantified using
the BCA assay (Cat # 23225, Thermo Fisher Scientific). Quantified protein samples were combined with Laemmli
Sample Buffer (Cat # 1610747 A, Bio-Rad) containing 10% β-mercaptoethanol (BME), heated to 37 °C for 10 minutes or otherwise indicated temperature, and loaded onto precast gels - AnykD (Cat # 5671125, Bio-Rad) or
4–20% (Cat # 5671095, Bio-Rad). We found that the AnykD gels were best for resolving the ADIPOR1 eye signal
doublet. Gels were ran on a Criterion Cell system (Bio-Rad). Gel transfer onto nitrocellulose membranes (Cat
# IB23001, Thermo Fisher Scientific) was performed using the iBlot 2 system (Cat # IB21001, Thermo Fisher
Scientific). Blots were blocked with 5% non-fat dry milk (NFDM, Cat # 9999, Cell Signaling Technology, Danvers,
MA) in PBS for 1 hour at room temperature (RT). Blots were incubated with primary antibodies in 0.05% Tween20 (Cat # 161–0781, Bio-Rad) with 5% NFDM in PBS overnight at 4 °C. After primary antibody incubation, blots
were washed with PBS + 0.05% Tween-20 and incubated with secondary HRP-coupled antibodies for 1 hour
at RT. After secondary antibody washing, blots were developed using Clarity Western ECL Substrate (Cat
# 1705061, Bio-Rad) and imaged using the FluorChem M system (ProteinSimple). Precision plus dual color
protein ladder (Cat # 1610374, Bio-Rad) was used to assess molecular weight. For list of antibodies used see
Supplementary Table S1.
For ADIPOR1 protein analysis across different mouse tissues, adult mouse tissue protein lysate from C57BL/6 J
mice was used (Cat #: MT-101-C57 skin, MT-102-C57 skeletal muscle, MT-103-C57 adipose tissue, MT-106-C57
eye, MT-313-C57 pancreas, MT-314-C57 liver, MT-201-C57 brain, MT-801-C57 heart, MT-901-C57 kidney Zyagen, San Diego, California). Zyagen brain samples contained whole brain tissue lysate while brain tissue from
WT and KO AdipoR1 animals was dissected as a piece of the cerebral cortex. No specific region of the cerebral
cortex was collected. A total of 40 µg of protein was loaded per lane. Post western blot analysis, Amido Black
staining solution (Cat # A8181, Sigma) was used to verify equal transfer and to assess protein levels.

™

™

™

Data Availability Statement

All data generated or analyzed during this study are included in this article, and its Supplementary Information
files.
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